Anti-GPCR RDC1/CXCR-7 antibody [EPR9321]
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(13 Publications)
Rabbit Recombinant Monoclonal GPCR RDC1/CXCR-7 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 13 publications.
View Alternative Names
CMKOR1, CXCR7, GPR159, RDC1, ACKR3, Atypical chemokine receptor 3, C-X-C chemokine receptor type 7, Chemokine orphan receptor 1, G-protein coupled receptor 159, G-protein coupled receptor RDC1 homolog, CXC-R7, CXCR-7, RDC-1
- WB
Unknown
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (AB138509)
All lanes:
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (ab138509) at 1/1000 dilution
Lane 1:
THP-1 cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
Raji cell lysate at 10 µg
Lane 4:
C6 cell lysate at 10 µg
Lane 5:
Raw 264.7 cell lysate at 10 µg
Lane 6:
NIH3T3 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 41 kDa
Observed band size: 41 kDa
false
- WB
Unknown
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (AB138509)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (ab138509) at 1/10000 dilution
All lanes:
THP-1 (Human monocytic leukemia monocyte) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 41 kDa
false
- WB
Unknown
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (AB138509)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-GPCR RDC1/CXCR-7 antibody [EPR9321] (ab138509) at 1/10000 dilution
Lane 1:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 15 µg
Lane 2:
C6 (Rat glial tumor glial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 41 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GPCR RDC1/CXCR-7 takes part in complex cell signaling related to cell growth survival and migration. It is not usually part of a classic GPCR signaling pathway which sets it apart from other receptors in its family. Instead it can modulate pathways by forming heterodimers with other receptors such as CXCR4 affecting both ligand availability and receptor sensitivity. CXCR-7 can also function as a decoy receptor binding ligands without initiating a typical signaling cascade.
Pathways
The participation of GPCR RDC1/CXCR-7 is noted in chemokine-mediated pathways. Of particular importance is the SDF-1/CXCL12 signaling pathway which it shares with CXCR4. This pathway plays an important role in the regulation of stem cell migration and homing. CXCR-7 modulates the bioavailability of CXCL12 and influences how CXCR4 triggers downstream effects affecting cellular response to the external environment.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Cells 13: PubMed38994928
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational pediatrics 12:1634-1645 PubMed37814711
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:7425-7438 PubMed35264069
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 8:652443 PubMed34746227
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 12:264 PubMed33941256
2021
Applications
Unspecified application
Species
Unspecified reactive species
Marine drugs 19: PubMed33805447
2021
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 21:287 PubMed33129326
2020
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 69:167-178 PubMed31865399
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 18:1091-1098 PubMed31316604
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 364:175-183 PubMed29408206
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com